The new Fair Lawn, New Jersey-based facility, which will expand the company’s capabilities to conduct a range of dermatological safety studies, will join three other TKL Research clinics in northern New Jersey. The company also has expertise in gastroenterology, respiratory, endocrinology and women’s health.
Reid Tripp, VP of business development, told us that the “addition of the new facility is based on increase client demand” in Phase I clinical trials.
The company also offers clinical trial management services, from strategy and protocol development to biostatistics, medical writing and regulatory submission.
TKL in 2006 moved its CRO operations to Rochelle Park, New Jersey, and later expanded its European capabilities with clinical operations in Münster, Germany, in 2010.